Locations:
Search IconSearch

eDosimetry Consult Service Helps Design Treatment Plans From Afar

Complex patients benefit from expert dosimetry teams

eDosimetry_650x450

Identification of optimal dosing for multifocal cancers or cancers around sensitive organs can prove difficult for cancer treatment teams, whose ideal approach balances tumor lysing with healthy tissue sparing.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Such was the case of a recent bilateral breast cancer patient, whose trimodality treatment necessitated radiation around the sternum, heart and lungs.

The patient is a 54-year-old female who presented with bilateral breast-infiltrating ductal carcinoma with 1.3 cm mass in the right breast and 3.4 cm mass in the left breast. Treatment included radiation, in addition to neoadjuvant chemotherapy with trastuzumab, pertuzumab, docetaxol and carboplatin. After chemotherapy, she underwent bilateral mastectomies with expander reconstruction.

“Like many of the more difficult cases we see, this patient posed a challenge in that our treatment team was committed to curing her cancer while also positioning her for the most fulfilling life possible after she walked out the door,” says Ping Xia, PhD, head of Medical Physics in the Department of Radiation Oncology.

Senior medical dosimetrist Eric Murray, under guidance of Dr. Xia, designed the following radiation treatment plan, which minimized exposure to critical organs while maximizing therapeutic effect:

  • Total dose 5040cGy with boost plan to PET post sternum and neck
  • Single isocenter IMRT
  • PET Positive Sternal Met, bilateral axillas and supraclavs and R Neck
  • Whole Lung V20 35%
  • Heart mean dose 600cGy

This planning CT scan of a bilateral breast cancer patient shows radiation exposure levels and was designed by the Medical Dosimetry team at Cleveland Clinic. At the time of publication, the patient remains disease free with fully functional organs

This planning CT scan of a bilateral breast cancer patient shows radiation exposure levels and was designed by the Medical Dosimetry team at Cleveland Clinic. At the time of publication, the patient remains disease free with fully functional organs.

image2_615x615

Treatment planning in dosimetry as piece of treatment puzzle

As oncology moves toward treating the entire patient, including quality-of-life considerations and overall wellness after treatment, treatment planning in dosimetry has emerged as an important piece of the treatment puzzle.

Advertisement

Patients and treatment teams rely on radiation oncologists, physicists and dosimetrists to craft individualized therapeutic plans that deliver favorable outcomes measured not only by disease-free survival but also by overall patient health and wellness.

In challenging cases, such as bilateral breast, head and neck, brain and other malignancies arising in sensitive areas, dosimetry teams are positioned to serve as critical participants in the treatment planning process.

However, hospitals and clinics outside major metropolitan areas often lack the patient volume to justify dedicated dosimetry personnel. Additionally, treatment centers with only one or two full-time dosimetrists remain subject to issues of staff turnover, burnout and family and medical leave.

These staffing gaps are frequently addressed through traveling contractors or remote dosimetry services. Traveling dosimetrists can be expensive, not only because of staff time but also because rates typically include travel, lodging, per diems and other ancillary expenses. These costs either must be shifted to the patient or absorbed by the treating institution. Neither choice offers particularly attractive solutions.

eDosimetry solutions

Cleveland Clinic now offers the dosimetry services provided to the patient described above to any institution anywhere in the world through its eDosimetry Consult Service.

This service allows all laboratory, imaging and treatment to be completed at the patient’s location of preference—usually somewhere close to home—while the dose planning and treatment design is completed at Cleveland Clinic by a team of more than a dozen experienced professionals.

Advertisement

When treatment teams in remote locations request services, radiologists at the treating institution are asked to complete a CT scan for planning purposes, which the eDosimetry Team can use to design treatment plans in collaboration with current providers.

The process is flexible and designed to be as integrative or hands off as needed to match the needs of the requesting organization and their patients. Dosimetrists need not travel. Patients receive optimal care in place. Communication and file transfers are secure and HIPAA compliant. Treatment teams can be confident in the expertise of Cleveland Clinic’s providers, and patients from any institution can benefit.

Advertisement

Related Articles

Hands after RT
January 30, 2026/Cancer/Radiation Oncology
Patient Case Study: Radiation Therapy Used to Treat Dupuytren's Disease

Radiation therapy helped shrink hand nodules and improve functionality

Dr. Ali and patient
January 29, 2026/Cancer/News & Insight
Real-World Data Reveals Gap Between Guidelines and Practice in HER2+ Breast Cancer Care

Standard of care is linked to better outcomes, but disease recurrence and other risk factors often drive alternative approaches

Dr. Thomas Budd
January 28, 2026/Cancer/Innovations
Breast Cancer Vaccine Moves One Step Forward

Phase 1 study demonstrates immune response in three quarters of patients with triple-negative breast cancer

Dr. Mukhejee and colleagues
January 22, 2026/Cancer/News & Insight
Rare Cancers and Blood Disease Program Accelerates Diagnostic Journey

Multidisciplinary teams bring pathological and clinical expertise

genetic test
January 16, 2026/Cancer/News & Insight
Five Percent of U.S. Population Carries Pathogenic Variants Associated with Cancer Risk

Genetic variants exist irrespective of family history or other contributing factors

GLP-1
January 12, 2026/Cancer/Blood Cancers
GLP-1a Therapy Improves Survival in Patients with Polycythemia Vera and Myelodysplastic Syndromes

Study shows significantly reduced risk of mortality and disease complications in patients receiving GLP-1 agonists

Oncology nurse
January 9, 2026/Cancer
Improving Patient Experience in Inpatient Hematology: A Nursing Perspective

Structured interventions enhance sleep, safety and caregiver resiliency in high-acuity units

PET scan
January 7, 2026/Cancer/Blood Cancers
Case Study: 21-Year-Old Patient with Refractory T-Cell Lymphoma

Addressing rare disease and challenging treatment course in an active young patient

Ad